• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

InterMune Inc

+ Add to Watchlist


73.8500 USD 0.1500 0.20%

As of 20:10:00 ET on 09/19/2014.

Snapshot for InterMune Inc (ITMN)

Open: 73.7200 Day's Range: 73.6200 - 74.2400 Volume: 5,765,124
Previous Close: 73.7000 52wk Range: 10.9500 - 74.2400 1-Yr Rtn: +389.40%

Stock Chart for ITMN

No chart data available.
  • ITMN:US 73.7200
  • 1D
  • 1M
  • 1Y
Interactive ITMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ITMN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.5609
Est. EPS (USD) (12/2014) -2.7470
Est. PEG Ratio -
Market Cap (M USD) 7,973.52
Shares Outstanding (M) 107.97
30 Day Average Volume 5,874,643
Price/Book (mrq) 22.3514
Price/Sale (ttm) 59.7092
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ITMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ITMN

InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.

Daniel G Welch "Dan"Chairman/President/CEOJohn HodgmanExec VP/CFO
Sean P NolanExec VP/Chief Business OfficerGiacomo Di NepiExec VP/Managing Dir:Europe
More Company Profile & Key Executives for ITMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil